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The mechanisms that tightly control the transcrip-
tion of host defense genes have not been fully eluci-
dated. We previously identified TFEB as a transcrip-
tion factor important for host defense, but the
mechanisms that regulate TFEB during infection
remained unknown. Here, we used C. elegans to
discover a pathway that activates TFEB during
infection. Gene dkf-1, which encodes a homolog of
protein kinaseD (PKD), was required for TFEB activa-
tion in nematodes infected with Staphylococcus
aureus. Conversely, pharmacological activation of
PKD was sufficient to activate TFEB. Furthermore,
phospholipase C (PLC) gene plc-1 was also required
for TFEB activation, downstream of Gaq homolog
egl-30 and upstream of dkf-1. Using reverse and
chemical genetics, we discovered a similar PLC-
PKD-TFEB axis in Salmonella-infected mouse mac-
rophages. In addition, PKCa was required in macro-
phages. These observations reveal a previously
unknown host defense signaling pathway, which
has been conserved across one billion years of
evolution.
INTRODUCTION
Host defense against infection relies on the transcriptional in-
duction of genes that encode antimicrobial proteins and sys-
temic signaling factors (Medzhitov and Horng, 2009). Great
strides have been made in understanding the functions of anti-
microbials, such as antimicrobial peptides and C-type lectins,
and of cytokines and chemokines, such as tumor necrosis fac-
tor a (TNF-a), interleukin 1b (IL-1b), and IL-6 (Bhatt et al., 2012;
Gallo and Hooper, 2012). In contrast, less is understood about
the regulatory networks that control their expression during
infection, except for a few examples, such as NF-kB (Amit
et al., 2009; Shapira and Hacohen, 2011). Host defense gene
expression is tightly regulated, and their misexpression can
cause chronic inflammation and autoimmunity (Medzhitov and
Horng, 2009). Therefore, understanding transcriptional control1728 Cell Reports 15, 1728–1742, May 24, 2016 ª 2016 The Authors
This is an open access article under the CC BY-NC-ND license (http://of host defense is of great relevance to infectious and inflam-
matory diseases.
We previously showed that transcription factor EB (TFEB)
is an important and evolutionarily conserved transcriptional
regulator of the host response to infection (Visvikis et al.,
2014). Caenorhabditis elegans TFEB, known as helix-loop-helix
domain (HLH)-30, is necessary and sufficient for host defense
gene expression. HLH-30 becomes rapidly activated during
infection, as revealed by its relocalization from the cytosol to
the nucleus of most cells in the organism. Furthermore, TFEB
rapidly relocalizes to the nucleus in murine macrophages,
where it also is necessary and sufficient for the expression of
downstream defense genes. The mechanisms by which nema-
tode and murine TFEB are activated during infection remained
unknown.
Previous studies showed that phosphorylation of TFEB by
mTORC1 or extracellular signal-regulated kinase (ERK) 2 results
in its cytoplasmic retention (Pen˜a-Llopis et al., 2011; Roczniak-
Ferguson et al., 2012; Sardiello et al., 2009; Settembre et al.,
2011). Such inhibition is lifted by nutritional deprivation in nema-
todes and mammalian cells (Lapierre et al., 2013; Martina et al.,
2012; O’Rourke and Ruvkun, 2013; Settembre et al., 2013). Acti-
vated TFEB drives the expression of lysosomal and autophagy
genes that are part of the Coordinated Lysosomal Expression
and Regulation (CLEAR) regulatory network (Palmieri et al.,
2011), which also includes lipid catabolism genes that are impor-
tant for cellular metabolic reprogramming (Settembre et al.,
2013). Activation of TFEB is much less understood. In nutrient-
deprived cells, it entails Ca2+-mediated calcineurin activation,
resulting in dephosphorylation of TFEB at mTORC1 target sites
and its nuclear import (Medina et al., 2015). Whether this mech-
anism is involved in TFEB regulation during infection is not
known.
Here, we report the discovery of an evolutionarily conserved
upstream pathway dependent on protein kinase D (PKD) for
the positive regulation of TFEB during infection. In C. elegans,
PKD homolog DKF-1 is essential for HLH-30 activation during
infection. In murine macrophages, we find that PKD activity is
also required for TFEB activation during infection, as is that of
PKCa. Thus, our study identifies a role for PKD in innate immune
signaling via TFEB in nematodes and mammals, and suggests
that PKD and TFEB may perform wider and more central roles
in host defense than previously appreciated.creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. DKF-1/PKD Is Necessary and Sufficient for HLH-30/TFEB Activation
(A) HLH-30::GFP animals were reared on E. coli carrying empty vector (EV), dkf-1RNAi, or dkf-2RNAi, and subsequently fedwith E. coliOP50 (top row) or infected
with S. aureus (middle row). Shown are representative epifluorescence micrographs. Hatched boxes indicate areas enlarged in detail (bottom row).
(B) Quantitative analysis. Data are mean ± SEM (two biological replicates, nR 50 per condition). ***p% 0.001 (two-sample t test).
(C) Survival of wild-type and hlh-30 mutant animals reared on E. coli carrying dkf-1 RNAi or empty vector control prior to infection with S. aureus. ***p% 0.001
(log-rank test).
(D) Animals were treated with dkf-1 RNAi as in (A) and subsequently incubated with 1 mg/ml PMA for 30 min. Shown are representative epifluorescence
micrographs (middle row). Hatched boxes indicate areas enlarged in detail (bottom row). Top row shows animals treated with vehicle.
(E) Quantitative analysis. Data are mean ± SEM (two biological replicates, nR 50 per condition). **p% 0.01 (two-sample t test).
(legend continued on next page)
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RESULTS
C. elegans DKF-1/Protein Kinase D Is Necessary and
Sufficient for the Activation of HLH-30/TFEB
C. elegans possess a TFEB ortholog named HLH-30 (Lapierre
et al., 2013; Visvikis et al., 2014). GFP-tagged HLH-30 (HLH-
30::GFP) is expressed throughout the body in uninfected animals
feeding on nonpathogenic Escherichia coli, where it distributes
equally between the cellular cytosol and nucleus. In contrast,
HLH-30::GFP concentrates in the cell nucleus throughout the
entire organism during infection with Staphylococcus aureus,
indicating that HLH-30 is activated by infection. We observed
similar behavior for murine TFEB in macrophages (Visvikis
et al., 2014). To clarify upstream regulation of TFEB, we sought
to identify candidate signaling molecules that are required for
TFEB activation during infection. We used C. elegans as a
gene discovery tool, with which we screened a library containing
RNAi constructs that target most protein kinases and phospha-
tases in the C. elegans genome (Manning, 2005). For the screen,
animals were reared on E. coli clones expressing double-
stranded RNA (dsRNA) to each gene individually (see Experi-
mental Procedures). The screen consisted of visual examination
of HLH-30::GFP nuclear localization by epifluorescence micro-
scopy after 30 min of S. aureus exposure. In this manner, we
found that inhibition of gene dkf-1 prevented HLH-30 nuclear
localization during S. aureus infection (Figures 1A and 1B).
Gene dkf-1 encodes one of two C. elegans homologs of PKD
(Feng et al., 2006; Fu and Rubin, 2011). Knockdown of dkf-1 spe-
cifically reduced dkf-1 mRNA by 50%, but not that of parala-
gous gene dkf-2 (Figure S1A). Furthermore, dkf-2 RNAi did not
affect HLH-30 activation (Figures 1A and 1B), suggesting that
dkf-1 specifically controls HLH-30 activation during infection.
Consistent with this result, dkf-1 RNAi knockdown severely
compromised host survival of S. aureus infection (Figure 1C).
Interestingly, dkf-1 knockdown in the hlh-30mutant background
did not impair host survival beyond that of the control hlh-30
mutant alone (p > 0.01, log-rank test), which suggested that
dkf-1 and hlh-30 may function in the same pathway. Non-in-
fected control experiments revealed that inhibition of dkf-1 re-
sulted in shortened lifespan (Figure S1B), such as has been
shown for hlh-30 (Lapierre et al., 2013; Settembre et al., 2013;
Visvikis et al., 2014). In contrast, dkf-1(ok2695), a partial loss-
of-function allele of dkf-1 that is sufficient to cause posterior
body paralysis (Feng et al., 2007) resulted in non-significant
reduction of host survival of infection (p = 0.1277), likely because
paralysis is insufficient to compromise host defense (FigureS1C).(F) qRT-PCR of ilys-2 in wild-type or hlh-30mutants. Animals were incubated with
are mean ± SEM (three biological replicates, three technical replicates, nR 3,00
(G) qRT-PCR of ilys-2 in worms reared on E. coli carrying empty vector control o
normalized to empty vector control. *p% 0.05 (two-sample t test).
(H) HLH-30::GFP animals were treated with kb-NB142-70 or bisindolylmaleimide
(middle row). Shown are representative epifluorescence micrographs. Hatched b
(I) Quantitative analysis. Data are mean ± SEM (two biological replicates, nR 50
(J) HLH-30::GFP animals were reared on E. coli carrying empty vector (EV), pkc-1,
are representative epifluorescence micrographs. Hatched boxes indicate areas e
(K) Quantitative analysis. Data are mean ± SEM (three biological replicates, nR
See also Figure S1.
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that are essential for HLH-30 activation during infection.
DKF-1 was previously shown to be activated by the second
messenger 1,2-diacylglycerol (DAG) in a PKC-independent
manner and can be activated using the DAG analog phorbol
12-myristate 13-acetate (PMA) (Feng et al., 2007). Exogenous
addition of PMA was sufficient to induce HLH-30 translocation
(Figures 1D and 1E) and induction of HLH-30-dependent
gene ilys-2 (Visvikis et al., 2014) (Figures 1F and 1G) in the
absence of infection. Such effects were diminished as a result
of dkf-1 knockdown (Figures 1D, 1E, and 1G), demonstrating
that PMA-triggered HLH-30 activation is DKF-1-dependent.
Together, these results show that activation of PKD homolog
DKF-1 is necessary and sufficient to induce HLH-30 activation.
PMA can also activate protein kinase C (PKC). To test whether
PKC might also be involved in HLH-30 activation during infec-
tion, we examined the effect of chemical inhibition of PKC on
HLH-30 nuclear translocation. Animals that were treated with
vehicle alone or with PKC inhibitor bisindolylmaleimide IV (Jirou-
sek et al., 1996) were indistinguishable (Figures 1H and 1I). In
stark contrast, treatment with PKD inhibitor kb-NB142-70 (Hari-
kumar et al., 2010) resulted in a 75% inhibition of HLH-30 trans-
location, supporting the findings with dkf-1 RNAi. Furthermore,
individual loss of PKC paralagous genes pkc-1, pkc-2, and
tpa-1 did not affect HLH-30 translocation (Figures 1J and 1K)
or ilys-2 induction (Figure S1D). Together, these results support
a key role for dkf-1, but not dkf-2 or PKC, in the activation of HLH-
30 during infection.
C. elegans EGL-30/Gaq and PLC-1/PLCε Are Necessary
for the Activation of HLH-30
We hypothesized that infection may result in increased cellular
DAG levels, thus causing PKD activation. A common endoge-
nous source of DAG is phosphatidyl inositide 4,5-bisphosphate
(PIP2), which is hydrolyzed to inositol trisphosphate (IP3) and
DAG by phospholipase C (PLC) (Kadamur and Ross, 2013).
PLC can be activated by interaction with a subunits of heterotri-
meric Gq proteins, or Gaq (Taylor et al., 1991). Furthermore, pre-
viouswork showed that theC. elegansGaq homolog EGL-30 can
activate PLCb homolog EGL-8 for host defense against Pseudo-
monas aeruginosa or Microbacterium nematophilum infection
(Kawli et al., 2010; McMullan et al., 2012). In addition, activation
of EGL-30 during fungal infection triggers EGL-8 and Ca2+
release to activate dual oxidase, or Duox (Zou et al., 2013).
With this precedent in mind, we investigated the role of the
EGL-30/EGL-8 axis in HLH-30 activation by infection.1 mg/ml PMA for 8 hr. Results are normalized to control wild-type animals. Data
0 per condition).
r dkf-1 RNAi. Animals were incubated with 1 mg/ml PMA for 8 hr. Results are
IV and subsequently fed with E. coli OP50 (top row) or infected with S. aureus
oxes indicate areas enlarged in detail (bottom row).
per condition). **p% 0.01 (two-sample t test).
pkc-2, or tpa-1RNAi and subsequently infected withS. aureus (top row). Shown
nlarged in detail (bottom row).
50 per condition).
Figure 2. A Gaq-PLCε-PKD Pathway Con-
trols TFEB in C. elegans
(A) HLH-30::GFP animals were reared on E. coli
carrying empty vector or egl-30 RNAi, and
subsequently infected with S. aureus. Shown
are representative epifluorescence micrographs.
Hatched boxes indicate areas enlarged in detail.
EV, empty vector control RNAi.
(B) Quantitative analysis. Data are mean ± SEM
(two biological replicates, n R 50 per condition).
***p% 0.001 (two-sample t test).
(C) Survival of wild-type and egl-30mutant animals
infected with S. aureus. ***p % 0.001 (log-rank
test).
(D) HLH-30::GFP animals were reared on E. coli
carrying empty vector or plc-1, plc-2, plc-3, plc-4,
or egl-8 RNAi and subsequently infected with
S. aureus. Shown are representative epifluor-
escence micrographs.
(E) Quantitative analysis. Data are mean ± SEM
(two biological replicates, n R 50 per condition).
***p% 0.001 (two-sample t test).
(F) Animals were treatedwith dkf-1, plc-1, or egl-30
RNAi and subsequently incubated with 1 mg/ml
PMA for 30 min. Shown are representative epi-
fluorescence micrographs (top row). Hatched
boxes indicate areas enlarged in detail (bottom
row).
(G) Quantitative analysis. Data are mean ± SEM
(two biological replicates, n R 50 per condition).
***p% 0.001 (two-sample t test).
(H) Proposed hypothetical model for HLH-30
regulation by infection.First, we tested whether EGL-30 might be important for HLH-
30 activation. RNAi knockdown of gene egl-30 resulted in
severely defective HLH-30 nuclear localization after infection
(Figures 2A and 2B). In addition, loss of function egl-30 mutants
were highly susceptible to S. aureus infection compared with
wild-type (Figure 2C), consistent with the putative role of EGL-
30 upstream of PLC.
Next, we addressed whether EGL-8 might also participate in
HLH-30 regulation. In this case, RNAi knockdown of gene egl-8
did not affect HLH-30 (Figures 2D and 2E), suggesting that
another PLC homolog may be involved. To identify the hypo-
thetical phospholipase that may function upstream of HLH-30
during infection, we performed RNAi-mediated knockdown
of additional PLC genes plc-1, plc-2, plc-3, and plc-4. While
animals treated with plc-2, plc-3, or plc-4 RNAi were indistin-
guishable from empty vector controls, plc-1 knockdown abro-
gated HLH-30::GFP nuclear localization (Figures 2D and 2E).Cell RUnexpectedly, plc-1 RNAi conferred en-
hanced survival of infection (Figure S1E).
In contrast, plc-1 RNAi caused short-
ened lifespan on nonpathogenic E. coli
(Figure S1F); thus, the observed resis-
tance to infection is not explained by
an extended lifespan. Loss of plc-1 has
been reported to cause pleiotropic de-
fects in multiple processes, including
fertilization (Kovacevic et al., 2013) and morphogenesis (Va´z-
quez-Manrique et al., 2008). In addition, plc-1 RNAi causes de-
fects in chromosome condensation and embryonic lethality
(Va´zquez-Manrique et al., 2008). Because PLC-1 participates
in numerous organismal functions, the observed lifespan phe-
notypes could be affected in a complex manner by plc-1
RNAi. Nonetheless, our finding that PLC-1 is required for
HLH-30 nuclear import suggests that PLC-1 is specifically
required for HLH-30 activation by infection.
To examine whether EGL-30 and PLC-1 might function up-
stream of DKF-1, we tested the ability of PMA to suppress the
phenotypes caused by their loss of function in terms of HLH-
30 activation. PMA caused HLH-30 translocation in animals
treated with RNAi against plc-1 or egl-30, but not in those treated
with dkf-1 RNAi (Figures 2F and 2G). This result suggested that
DAG produced downstream of EGL-30 and PLC-1 can activate
DKF-1 and HLH-30 translocation.eports 15, 1728–1742, May 24, 2016 1731
Together, these data suggest a hypothetical model whereby
infection triggers an unknown G protein-coupled receptor
(GPCR X; Figure 2H), which could activate PLC-1 via EGL-30
(although more complex indirect scenarios are also possible).
PLC-1 generates DAG, which recruits DKF-1 to the membrane,
resulting in its activation. Directly or indirectly, activated DKF-1
causes HLH-30 to concentrate in the nucleus, where it can drive
the expression of host defense genes such as ilys-2. Because
HLH-30 and its mammalian homolog TFEB are both regulated
by infection, we hypothesized that a similar pathway might oper-
ate in mammalian innate immune cells.
Murine PKD1 Is Necessary and Sufficient for TFEB
Activation in Macrophages
To test whether PKD regulates TFEB also in macrophages, we
incubated TFEB-GFP RAW264.7 cells with PKD inhibitors. Com-
pounds kb-NB142-70 and CRT0066101 were previously identi-
fied as specific PKD antagonists (Harikumar et al., 2010; LaValle
et al., 2010). Preincubation with either compound prevented
TFEB nuclear translocation upon subsequent Salmonella infec-
tion (Figures 3A–3C0, 3G, 3H, S2A–S2C0, S2F, and S2G), indi-
cating that PKD is required for TFEB activation. In addition,
CRT0066101 caused ectopic localization of TFEB to unknown
structures resembling vesicles (Figures S2C and S2C0). Further-
more, short hairpin RNA (shRNA)-mediated knockdown showed
that genes Prkd2 and Prkd3, encoding PKD2 and PKD3 respec-
tively, were dispensable for TFEB activation by Salmonella, while
Prkd1, encoding PKD1, was absolutely required (Figures 3I–3O).
Control experiments showed that Prkd1 shRNA specifically
reduced expression of PKD1 by 80% (Figures 3P and 3Q).
Together, these results suggested that PKD1 activity is required
for TFEB activation during infection.
As mentioned, we found that PMA can activate HLH-30 in
C. elegans, in a manner dependent on PKD homolog DKF-1.
To test whether PMA can also activate TFEB through PKD in
macrophages, we incubated TFEB-GFP RAW264.7 cells with
PMA. Such treatment was sufficient to induce TFEB nuclear
translocation in the absence of infection (Figures 4A–4B0, 4G,
and 4H). Furthermore, inhibition of PKD using compounds
kb-NB142-70 or CRT0066101 completely abrogated this effect
(Figures 4C–4D0, 4G, and 4H). TFEB electrophoretic mobility
changes due to phosphorylation (Visvikis et al., 2014). We
noticed subtly altered electrophoretic mobility of TFEB as soon
as 10min after PMA incubation, which reverted after 30min (Fig-
ures 4I and 4J). In addition, we observed a slight increase in
TFEB levels after PMA incubation. Although they do not ascribe
the slower mobility to direct phosphorylation of TFEB by PKD,
these observations indicate that PKD activation is necessary
and sufficient for TFEB nuclear translocation during infection.
Murine PKC Is Necessary and Sufficient for TFEB
Activation in Macrophages
DKF-1 was previously shown to become activated by DAG in a
PKC-independent manner (Feng et al., 2007). In contrast, in
mammalian cells, PKD can also be activated by PKC (Rozengurt,
2011). To test the importance of PKC for TFEB activation, we
preincubated TFEB-GFP RAW264.7 cells with selective PKC in-
hibitors and subsequently infected them with Salmonella. Incu-1732 Cell Reports 15, 1728–1742, May 24, 2016bation with Go¨ 6983 and bisindolylmaleimide IV, which inhibit
all PKC isozymes (Gschwendt et al., 1996; Smith and Hoshi,
2011), abrogated TFEB activation (Figures 3D, 3D0, 3G, 3H,
S2D, S2D0, S2F, and S2G). Furthermore, incubation with
HBDDE, which inhibits PKCa and PKCg (Kashiwada et al.,
1994), also prevented TFEB activation (Figures 3E, 3E0, 3G,
and 3H), whereas incubation with LY333531, which inhibits
PKCb (Jirousek et al., 1996), or PKCε inhibitor peptide (Johnson
et al., 1996) did not (Figures 3F–3H andS2E–S2G). Similar results
were obtained in TFEB-FLAG-expressing RAW264.7 cells in-
fected with live or dead S. aureus (Figure S3). These results sug-
gested that neither PKCb, whichwas previously shown to control
TFEB abundance in osteoclasts (Ferron et al., 2013), nor PKCε,
which is required for phagocytosis in macrophages (Castrillo
et al., 2001; Larsen et al., 2000), was required for TFEB activation
by infection. In contrast, PKCa and/or PKCg are required for
TFEB activation during infection.
Similar to PKD, PKC can be activated using PMA (Lin and
Chen, 1998). As with PKD inhibitors, HBDDE prevented TFEB
activation by PMA, whereas LY333531 did not (Figures 4E–
4H). Taken together, these data suggest that DAG generated
during infection may result in the activation of PKCa (or PKCg,
but not PKCb) and PKD1, both of which are required for TFEB nu-
clear translocation.
PKCa and PKD Are Quickly Activated by Infection in
Macrophages
Our results thus far suggested that PKCa/g and PKD1 were
important for TFEB activation during infection. However, it was
not clear whether they played a permissive role for TFEB activa-
tion, or if they might actively transduce a signal that triggers
TFEB translocation. PKC isozymes are constitutively phosphor-
ylated on specific Ser and Thr residues following translation, in a
process known as ‘‘maturation’’ (Wu-zhang and Newton, 2013).
C-terminal Ser916 phosphorylation of PKD isozymes results in
their activation (Kunkel and Newton, 2015). Thus, phosphoryla-
tion of specific residues can be used as a measure of PKCmatu-
ration and of PKD activation. To address whether PKC and PKD
might be differentially regulated during infection, we performed
western blot analysis of lysates from infected RAW264.7 cells.
We used antibodies that specifically recognize phosphorylated
PKCa/b, PKCd, PKCd/q, PKCz/l, and all three PKD isozymes
(see Experimental Procedures).
PKCd and PKCd/q phosphorylation did not vary considerably
over a 2-hr time course (Figures 5A–5C). In contrast, PKCz/l
phosphorylation decreased 5-fold (Figures 5A, 5D, and 5E).
Furthermore, PKCa/b phosphorylation increased 4-fold just
10 min after infection and remained 2-fold higher than baseline
after 2 hr (Figures 5A, 5F, and 5G). In addition, PKD became
phosphorylated by 10 min and reached a further 3-fold higher
level after 2 hr (Figures 5A and 5H). In contrast, total PKD dimin-
ished over time, about 10-fold after 2 hr (Figures 5A and 5I). TFEB
levels remained steady throughout, but its electrophoretic
mobility appeared to slightly increase with time (Figures 5A, 5J,
and S4A), consistent with decreased phosphorylation previously
observed upon activation and nuclear import (Medina et al.,
2015; Visvikis et al., 2014). Furthermore, preincubation with
PKD inhibitor kb-NB142-70 resulted in increased mobility even
Figure 3. PKD1 and PKCa/g Are Necessary for Activation of TFEB by Infection
TFEB-GFP RAW264.7 cells were preincubated with PKC and PKD inhibitors for 1 hr previous to infection with S. enterica (MOI = 100) for 2 hr. Shown are
representative images from one replicate and quantification of three biological replicates of three technical replicates each.
(A) DMSO control.
(A0) Detail.
(B) S. enterica SL1344.
(B0 ) Detail.
(C) 10 mM kb-NB142-70 (PKD inhibitor).
(C0) Detail.
(legend continued on next page)
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at early times of infection (Figures 5K, 5L, and S4B). Considered
together with our previous chemical inhibition results, these ex-
periments suggested that PKCa and PKD are promptly activated
after infection and are required for downstream TFEB activation.
Salmonella enterica Must Be Alive to Activate the
PKD-TFEB Pathway in Macrophages
Pattern recognition receptors (PRRs), such as Toll-like receptors
(TLRs), recognize molecules that form part of bacterial cells,
such as lipopolysaccharide (LPS). To investigate the potential
for such receptors to be involved in TFEB activation, we exam-
ined dead Salmonella, which possess such molecules and thus
should trigger PRRs as well as live Salmonella. To our surprise,
we found that heat-killed Salmonella did not increase PKD
phosphorylation (Figures 6A–6C) and thus would not activate
PKD. Consistent with this finding, we did not observe TFEB acti-
vation during incubation with either heat-killed or antibiotic-killed
Salmonella (Figures 6D–6I). Therefore, we concluded that under
these conditions, the PKD-TFEB pathway specifically responds
to live Salmonella.
PC-PLC Is Required for TFEBActivation inMacrophages
PKCa and PKD are activated by DAG. As mentioned previously,
intracellular DAG is generated by the action of PLC. Therefore,
we hypothesized that PLC may be required for activation of
PKCa and PKD upstream of TFEB. In support of this hypothesis,
we had found that theC. elegansPLC homolog PLC-1 is required
for the activation of the TFEB homolog HLH-30, as mentioned
previously. To further test this hypothesis, we examined the ef-
fect of PLC inhibitors on TFEB activation by infection. Inhibition
of phosphoinositide (PI)-PLC using U-73122 (Bleasdale et al.,
1990), or of phospholipases D1 and 2 (PLD1 and PLD2) using
VU0359595, CAY10594, FIPI, or halopemide (Lewis et al.,
2009; Monovich et al., 2007; Scott et al., 2009; Su et al., 2009),
did not affect TFEB activation (Figures 7D–7J). In contrast, inhi-
bition of phosphatidylcholine (PC)-PLC using D609 (Amtmann,
1996) effectively prevented TFEB nuclear translocation (Figures
7A–7C0, 7I, and 7J). Therefore, PC-PLC activity is required for
TFEB activation during infection, presumably by generating
DAG and thus activating PKCa and PKD. To further test this
idea, we measured PKD activation by Salmonella in D609-
treated macrophages by anti-phospho-PKD immunoblot. Unfor-(D) 5 mM Go¨ 6983 (pan-PKC inhibitor).
(D0) Detail.
(E) 1 mM HBDDE (selective inhibitor of PKCa and PKCg).
(E0) Detail.
(F) 10 mM LY333531 (selective inhibitor of PKCb1 and PKCb2).
(F0) Detail.
(G) Percentage of cells with nuclear translocation was measured with Gen5 anal
(H) GFP intensity in nucleus compared to cytoplasm (N/C ratio) was measured u
0.001 (one-way ANOVA followed by Tukey’s post hoc test). Scale bars, 100 mm.
(I–M0) TFEB-FLAG RAW264.7 cells were infected with Salmonella after shRNA tre
100 mm. (I) scrambled shRNA control with PBS. (I0 ) Detail. (J) Scrambled shRNA
SL1344. (K0) detail. (L) PKD2 shRNA with S. enterica SL1344. (L0 ) detail. (M) PKD
(N) Percentage of cells with nuclear translocation.
(O) GFP intensity in nucleus compared to cytoplasm (N/C ratio). **p% 0.01, ***p
(P) Anti- PKD1, PKD2, PKD3, and b-actin immunoblots of lysates from sh-PKD1
(Q) Quantitative analysis of PKD1 immunoblot, normalized to b-actin loading con
See also Figure S2.
1734 Cell Reports 15, 1728–1742, May 24, 2016tunately, inhibition of PC-PLC resulted in constitutive phos-
phorylation of PKD, even in the absence of infection (t = 0 min;
Figures 7K and 7L). Thus, it was not possible to assess the
effect of D609 during infection-induced phosphorylation of
PKD. Taken together, these observations suggest that the activ-
ity of mammalian TFEB is controlled by a PLC-PKD cascade, as
discovered using C. elegans (Figure 7M). By analogy with nema-
todes, it is possible that Gaq mediates activation of this cascade
by an unknown GPCR in macrophages.
DISCUSSION
Our previouswork established that TFEB is activatedduring infec-
tion in nematodes and macrophages, suggesting that TFEB is an
evolutionarily ancient component of host defense (Visvikis et al.,
2014). TFEB activation was required for the induction of host de-
fense genes in both nematodes and mammals (Visvikis et al.,
2014). Subsequent independent work showed that LPS can stim-
ulateTFEB,with important consequences forantigenpresentation
bydendritic cells (DCs) (SamieandCresswell, 2015). Furthermore,
activation of TFEB was shown to be important for host defense
against staphylococcal pore-forming toxins (Maurer et al., 2015).
Thus, the question of how TFEB is regulated during infection is
relevant to many aspects of host defense and inflammation. Pre-
vious work established that phosphorylation of TFEBbymTORC1
and ERK2 resulted in its cytoplasmic retention (Martina et al.,
2012; Pen˜a-Llopis et al., 2011; Sardiello et al., 2009) and that
such negative regulation was lifted during starvation stress by
the action of protein phosphatase calcineurin (Medina et al.,
2015). However, to date, no positive regulatory interaction had
been described. Furthermore, the upstream pathways important
for TFEB activation specifically during infection were unknown.
Here, we showed that a PLC-PKD pathway is necessary and
sufficient for TFEB activation in nematodes and mouse macro-
phages infectedwithSalmonella orS. aureus. An unbiased in vivo
reverse genetic screen performed using C. elegans revealed the
requirement of PKD homolog DKF-1 for HLH-30 activation by
infection, which led us to discover that PLCε homolog PLC-1
and Gaq homolog EGL-30 are also required.
These results suggest a hypothetical model in which infection
activates Gaq, presumably via an unidentified G protein coupled
receptor (GPCR X; Figure 7K). Gaq activates PLCε, whichysis software.
sing CellProfiler. See Experimental Procedures for details. **p% 0.01, ***p%
atment. Shown are anti-FLAG immunofluorescence micrographs. Scale bars,
control with S. enterica SL1344. (J0) detail. (K) PKD1 shRNA with S. enterica
3 shRNA with S. enterica SL1344. (M0) detail.
% 0.001 (one-way ANOVA followed by Tukey’s post hoc test).
, sh-PKD2, sh-PKD3, and scrambled control cells.
trol.
Figure 4. Activation of PKC or PKD Is Suffi-
cient for TFEB Activation
TFEB-GFP RAW264.7 cells were preincubated
with inhibitors for 1 hr previous to addition of
100 ng/ml PMA for 30 min. Shown are represen-
tative images from one replicate and quantification
of three biological replicates of three technical
replicates each.
(A) DMSO control.
(A0) Detail.
(B) DMSO plus PMA.
(B0) Detail.
(C) 10 mM kb-NB142-70 (specific PKD inhibitor).
(C0) Detail.
(D) 5 mM CRT0066101 (specific PKD inhibitor).
(D0 ) Detail.
(E) 1 mM HBDDE (selective inhibitor of PKCa and
PKCg).
(E0) Detail.
(F) 10 mM LY333531 (PKCb1 and PKCb2 inhibitor).
(F0) Detail.
Scale bars, 100 mm.
(G) Percentage of cells with nuclear translocation
was measured with Gen5 analysis software.
(H) GFP intensity in nucleus compared to cyto-
plasm (N/C ratio) was measured using CellProfiler.
Please see Experimental Procedures for more
detail. **p % 0.01, ***p % 0.001 (one-way ANOVA
followed by Tukey’s post hoc test).
(I) Images from immunoblot following addition of
100 ng/ml PMA. Primary antibodies are indicated
on the left.
(J) Quantitative analysis of TFEB immunoblot,
normalized to b-actin loading control.
See also Figure S3.generates DAG, resulting the activation of PKD. PKD activation is
required for TFEB nuclear translocation and downstream tran-
scription of host defense genes. Recent evidence supports a
role for PLC-1 downstream of EGL-30 for salt chemotaxis asCell Rwell (Kunitomo et al., 2013). We observed
a complex phenotype for knockdown of
plc-1. The products of PLC-1 activity,
IP3 and DAG, feed into many pathways,
complicating the evaluation of the rela-
tionship between the observed survival
phenotypes and HLH-30. This area re-
quires further exploration. However,
the one phenotype that is specific to
HLH-30, its nuclear localization during
infection, is clearly dependent on PLC-1.
This pathway resembles a previously
described pathway for epidermal tran-
scription of antimicrobial peptides
following infection by fungal pathogen
Drechmeria coniospora. In such pathway,
a GPCR-Ga12-PLCg-PKCd pathway con-
trols a STAT-type transcription factor (Di-
erking et al., 2011; Ziegler et al., 2009; Zu-
gasti et al., 2014). C. elegansGaq also has
known roles upstream of PLCb for the
regulation of host defense against P. aeruginosa and oxidative
stress (Kawli et al., 2010) and for the upregulation of transcription
factor DAF-16 in the epidermis during D. coniospora infection
(Zou et al., 2013). Furthermore, C. elegans Gaq was recentlyeports 15, 1728–1742, May 24, 2016 1735
Figure 5. PKD and PKCa Are Quickly Activated after Infection
(A–L) RAW264.7 cells were infected with S. enterica SL1344 (MOI = 100) for 0 (control), 10, 20, 30, 60, and 120 min, lysed, and subjected to immunoblot analysis.
Shown are representative results from three biological replicates.
(A) Images from immunoblots. Primary antibodies are indicated on the left.
(B–J) Quantitative analysis, normalized to b-actin loading control.
(K) Images from immunoblots after Salmonella infection plus 10 mM kb-NB142-70 (specific PKD inhibitor). Primary antibodies are indicated on the left.
(L) Quantitative analysis, normalized to b-actin loading control.shown to control both innate immunity and infection avoidance
behavior against M. nematophilum (McMullan et al., 2012). In
addition, DKF-2, which is paralogous to DKF-1, is controlled
by PKCd and is important in the intestine for p38 mitogen-acti-
vated protein kinase (MAPK)-mediated defense against Entero-
coccus faecalis and P. aeruginosa through dual oxidase (Duox)
BLI-3 (Feng et al., 2007; Hoeven et al., 2011; van der Hoeven
et al., 2012; Ren et al., 2009). Whether DKF-1 is also important
for HLH-30 activation in animals infected with Enterococcus fae-
calis or P. aeruginosa, or whether this might be dependent on
DKF-2 instead, remains to be determined. Activation of DAF-
16 by D. coniospora in the epidermis also requires Ca2+ release
and BLI-3 (Zou et al., 2013). Thus, the potential involvement of
Ca2+ and Duox in TFEB activation during infection deserves
further investigation in nematodes and mammals.
We find that key aspects of the proposed C. elegans GPCR-
Gaq-PLCε-PKD-TFEB pathway are conserved in mouse macro-
phages, where PLC, PKD1, and PKCa are all required for
TFEB activation bySalmonella. Murine PKCa and PKD are rapidly
activated following Salmonella infection, and PMA-mediated
stimulation of PKC and/or PKD is sufficient to activate TFEB
and downstream gene transcription in nematodes. These results
are consistentwith previous observations that PKC is quickly acti-1736 Cell Reports 15, 1728–1742, May 24, 2016vated in infected macrophages (von Knethen and Br€une, 2005),
that PKCa is required for the respiratory burst (Larsen et al.,
2000), and that PKD can induce autophagy (Eisenberg-Lerner
and Kimchi, 2012). Previous observations that PMA activates
TFEB in HEK293 cells lend further support (Huan et al., 2005).
We were unable to use PC-PLC inhibitor D609 to test whether
PKD activation is PLC dependent, because D609 incubation led
to constitutive PKD phosphorylation. Although the exact mecha-
nism is unknown, we suspect that a compensatory mechanism is
activated by tonic PC-PLC inhibition, which could lead to consti-
tutive PKD S916 phosphorylation (but not TFEB translocation).
Because inhibition of C. elegans gene plc-1 also yielded unex-
pected results, this topic is of great interest for future study. Taken
together, our findings demonstrate a PKD- and TFEB-dependent
mechanism of transcriptional regulation in response to infection,
which is evolutionarily ancient. It will be interesting to determine
under what other circumstances TFEB mediates PKD signaling.
PKC and PKD have been shown to regulate each other in other
systems (Rozengurt, 2011). Furthermore, recent studies have
implicated PKD1 as an important signaling molecule downstream
of TLR signaling through scaffold protein MyD88 in macrophages
and dendritic cells (Kim et al., 2010; Park et al., 2008, 2009). After
stimulation with TLR ligands such as LPS and flagellin, the
Figure 6. Salmonella enterica Must Be Alive
to Activate the PKD-TFEB Pathway in Mac-
rophages
(A) Anti-phospho-PKD immunoblot. RAW264.7
cells were incubated with live or dead S. enterica
SL1344 (MOI = 100) for 0 (control), 10, 20, 30, 60,
and 120 min, then lysed and subjected to immu-
noblot analysis.
(B and C) Quantitative analysis, normalized to
b-actin loading control.
(D–G) TFEB-GFP RAW264.7 cells were incubated
with live or dead S. enterica (MOI = 100) for 2 hr.
For the heat-killed condition, bacteria were
heated to 75C for 1 hr and 100% killing was
confirmed by culture for 48 hr on LB-streptomycin
agar at 37C. For antibiotic-killed bacteria, genta-
micin (100 mg/ml) was added to washed bacteria in
PBS for 2 hr and 100% killing was confirmed by
culture for 48 hr on LB-streptomycin agar at 37C.
Shown are representative images from one repli-
cate and quantification of three biological repli-
cates of three technical replicates each. (D) PBS
control. (E) Live S. enterica SL1344. (F) Heat-killed
S. enterica. (G) Antibiotic-killed S. enterica.
(H) Percentage of cells with nuclear translocation
was measured with Gen5 analysis software.
(I) GFP intensity in nucleus compared to cytoplasm
(N/C ratio) was measured using CellProfiler. **p%
0.01, ***p % 0.001 (one-way ANOVA followed by
Tukey’s post hoc test).production of TNFa requires PKD1. In cells depleted of PKD1,
TRAF6 fails tobecomeubiquitylated, effectively interruptingsignal
transduction to transcription factor NF-kB (Park et al., 2009). Our
results indicate that in addition to this known role in TLR-
MyD88-NF-kB signaling, PKD plays an important role in signaling
toTFEB.Our resultsareconsistentwithdirect signaling toTFEBby
PKD1. In addition, TFEB phosphorylation is PKD-dependent in
cytotoxic T cells (Navarro et al., 2014), and our bioinformatic anal-
ysis of the TFEB amino acid sequence revealed a putative PKD
consensusphosphorylation site in the TFEBN terminus.However,
we cannot presently rule out intermediate steps linking PKD1 to
TFEB. For example, PKD can activate theMAPK ERK in endothe-
lial cells (Wong and Jin, 2005). Nonetheless, in our system,MAPK/
ERK kinase (MEK) inhibitors did not prevent TFEB activation by
infection (M.N. and J.E.I., unpublished data), suggesting that
ERK signaling may not be required. Still, some other unknown
signaling component could link PKD to TFEB.Cell RExactly how TFEB becomes activated
during infection is not well understood.
TFEB abundance is positively regulated
through C-terminal phosphorylation by
PKCb in differentiated osteoclasts, as
part of a pathway downstream of RANKL
signaling (Ferron et al., 2013). However,
in that study, phosphorylation by PKCb
did not affect TFEB localization. Further-
more, we directly tested the role of
PKCb in activation of TFEB by infection.
Inhibition of PKCb using LY333531 didnot prevent TFEB activation by Salmonella or PMA, indicating
that PKCb is not required in these scenarios. Thus, TFEB abun-
dance, subcellular localization, and transcriptional activity are
subject to complex regulation in different cell types under
distinct circumstances. Further study is required to test the
relevance of such regulatory interactions in the context of
host-pathogen interactions and to elucidate the mechanistic ba-
sis of TFEB activation during infection. Answering these ques-
tions will provide important insights into what are likely to be
fundamental mechanisms of host-microbe interaction in many
organisms.EXPERIMENTAL PROCEDURES
Bacterial Strains
E. coli OP50 was a gift from Gary Ruvkun, Massachusetts General Hospital
(MGH) Research Institute. S. enterica serovar Typhimurium SL1344 was aeports 15, 1728–1742, May 24, 2016 1737
Figure 7. PC-PLC Activity Is Required for
TFEB Activation by Infection
TFEB-GFP RAW264.7 cells were preincubated
with PLC inhibitors for 1 hr prior to infection with
S. enterica (MOI = 100) for 2 hr. Shown are repre-
sentative images from one replicate, and quantifi-
cation of three biological replicates of three tech-
nical replicates each. Scale bars, 100 mm.
(A) DMSO control.
(A0) Detail.
(B) S. enterica SL1344.
(B0) Detail.
(C) 50 mM tricyclodecan-9-yl-xanthogenate
(D609), which inhibits phosphatidylcholine-spe-
cific phospholipase C (PC-PLC).
(C0) Detail.
(D) 50 mM U-73122, which inhibits phosphoinosi-
tide-specific phospholipase C (PI-PLC).
(D0) Detail.
(E) 10 mM VU0359595, which inhibits phospholi-
pase D1 (PLD1).
(E0) detail.
(F) 10 mMCAY10594, which inhibits phospholipase
D2 (PLD2).
(F0) Detail.
(G) 10 mM FIPI, which inhibits PLD1 and PLD2.
(G0) Detail.
(H) 10 mM halopemide, which inhibits PLD1 and
PLD2.
(H0) Detail.
(I) Percentage of cells with nuclear translocation
was measured with Gen5 analysis software.
(J) GFP intensity in nucleus compared to cyto-
plasm (N/C ratio) was measured using CellProfiler.
**p % 0.01, ***p % 0.001 (one-way ANOVA fol-
lowed by Tukey’s post hoc test).
(K and L) RAW264.7 cells were incubated with
50 mM D609 for 1 hr and then infected with
S. enterica SL1344 (MOI = 100) for 0 (control),
10, 20, 30, 60, and 120 min, lysed, and sub-
jected to immunoblot analysis. Shown are
representative results from three biological rep-
licates. (K) Images from immunoblots. Primary
antibodies are indicated on the left. (L) Quanti-
tative analysis, normalized to b-actin loading
control.
(M) Proposed genetic pathways for signal trans-
duction and activation of TFEB in C. elegans
and mammals by infection. Asterisk denotes
mammalian steps proposed by analogy with
C. elegans.gift from Brian Coombes (McMaster University). S. aureus NCTC8325 and
SH1000 (a functional rsbU+ derivative of 8325-4 rsbU) were gifts from Fred
Ausubel, MGH Research Institute.
C. elegans Strains
C. elegans were grown on nematode-growth media (NGM) plates seeded with
E. coli OP50 according to standard procedures (Powell and Ausubel, 2008).
C. elegans strains used in this study include N2 Bristol wild-type (Caenorhab-
ditis Genetics Center [CGC]), VT1584 hlh-30(tm1978)IV (CGC), RB2037 dkf-1738 Cell Reports 15, 1728–1742, May 24, 20161(ok2695)I (CGC), JIN1693 hlh-30(tm1978); jinIs10 [hlh-30p::hlh-30::gfp,rol-
6(su1006)].C. elegans qRT-PCR
After infection, C. elegans were washed twice in cold water and lysed in TRI
Reagent (Molecular Research Center). cDNA was obtained with SuperScript
III (Invitrogen) and analyzed as in Irazoqui et al. (2008). Data analysis was per-
formed using the Pfaffl method (Pfaffl, 2001).
C. elegans Infection
S. aureus SH1000 was grown overnight in tryptic soy broth (TSB) containing
50 mg/ml kanamycin (KAN). 10 ml overnight (ON) cultures was uniformly spread
on the entire surface of 35-mm trypticase soy agar (TSA) plates with 10 mg/ml
KAN and incubated 4–6 hr at 37C. RNAi-treated L4 larvae were first trans-
ferred onto new HT115 RNAi plates supplemented with 80–100 mg/ml 5-flu-
oro-20-deoxyuridine (FUDR) for 24 hr at 15C before transfer to S. aureus
plates. After FUDR treatment, 25–40 infertile animals were transferred to
each of three replicate infection plates per strain. Animals that died of bursting
vulva, matricidal hatching, or crawling off the agar were censored. Experi-
ments were performed at least twice.
RNAi by Feeding
RNAi was carried out using bacterial feeding RNAi (Timmons et al., 2001).
HT115 RNAi clones were obtained from the Ahringer genomic RNAi library
or the Vidal library when absent in the former. Clone identity was confirmed
by sequencing, and absence of off-target effects was verified against predic-
tions by the C. elegans genomic database resource, WormBase (http://www.
wormbase.org), and by qRT-PCR. For dkf-1 gene knockdown, young adults
were incubated 4 days at 15C on E. coli HT115 RNAi plates, so that the prog-
eny was exposed to dsRNA from embryo to L4 stage.
PMA Treatment of C. elegans
PMA treatment was performed on NGM plates supplemented with 1 mg/ml
PMA (Sigma). HLH-30::GFP animals were treated at the young adult stage
and incubated at room temperature with and without PMA. After 30 min, the
animals were harvested and prepared for imaging.
Longevity Assays
All assays were performed at 25C as described previously (Powell and Ausu-
bel, 2008). Animals were transferred by picking to NGM +OP50 plates supple-
mented with 80–100 mg/ml FUDR and incubated at 25C. Experiments were
performed at least twice. Kaplan-Meier survival analyses were performed us-
ing software Prism 5 (GraphPad). Survival data were compared using the log-
rank significance test.
C. elegans Preparation for Imaging
L4 animals expressing HLH-30::GFP were grown on NGM plates for 24 hr at
15C, then kept for 2 hr at room temperature, before transfer 30 min prior to
imaging onto S. aureus killing assay plates, PMA plates, or NGM plates used
as control. Animals were harvested by washing with M9W buffer (Powell and
Ausubel, 2008) and paralyzed with 10% NaN3 in 96-well plates. Image acqui-
sition was automatically performed using a Cytation 3 Imaging Plate Reader
(BioTek Instruments).
Statistical Analysis
Statistical analyses were performed using Prism 5 software (GraphPad). Sur-
vival data were compared using the log-rank test. Data are presented as me-
dian survival (MS), as defined by Kaplan-Meier analysis, or time to 50%
death (LT50), as defined by nonlinear regression. A p value % 0.05 was
considered significantly different from control. For qRT-PCR, two-sample,
two-tailed t test statistical analyses were performed to evaluate differences
among pooled DCt values according to Pfaffl (Pfaffl, 2001) using Excel. A
p value % 0.05 was considered significant. For imaging quantification,
two-sample, two-tailed t test statistical analyses were performed. Before
use of the t test, all values were confirmed for normal distribution by the
Agostino Pearson omnibus test.
Cell Culture and Transfection
RAW264.7 macrophages were grown in DMEM high glucose, GlutaMAX (Life
Technologies, 10566-024) containing 10% FBS (Life Technologies, 10082147)
and 1%antibiotic-antimycotic (Life Technologies, 15240-062). Cells were pas-
sage 4 to 11. RAW264.7 TFEB-GFP stably transfected cells were created us-
ing pEGFP-N1-TFEB (a gift from Shawn Ferguson, Addgene plasmid # 38119),
Lipofectamine LTX Reagent with PLUS Reagent (Life Technologies, A12621)
according tomanufacturer’s instructions, and G418 sulfate (Life Technologies,
10131). Ten days after selection, stable GFP+ cells were separated by fluores-cence-activated cell sorting (FACS). RAW264.7 cells stably expressing TFEB-
FLAG were a gift from Mathieu Ferron (Institut de Recherches Cliniques de
Montre´al) (Ferron et al., 2013). For drug screening, we used ViewPlate-96
well black opaque plates (Perkin Elmer, 6005182). 6 3 104 cells were seeded
in each well. At the end of the experiments, cells were fixed using 4% parafor-
maldehyde (Sigma-Aldrich, 158127) and incubated with Hoechst stain (Anas-
pec, AS-83218) at room temperature for 20 min as nuclear staining. Image
acquisition was automatically performed using a Cytation 3 Imaging Plate
Reader (BioTek Instruments).
shRNA Knockdown
Lentiviral shRNA plasmids were purchased from Dharmacon RNAi Technolo-
gies (PKD1: gene set, GIPZ Prkd1; shRNA, RMM4532-EG18760; PKD2: gene
set, GIPZ Prkd2; shRNA, RMM4532-EG101540; and PKD3: gene set, GIPZ
Prkd3; shRNA, RMM4532-EG75292). After plasmid preparation and diag-
nostic restriction enzyme digest, we used Lipofectamine 3000 (Thermo Fisher
Scientific) for transfection according to manufacturer’s instructions. For selec-
tion, we used 3 mg/ml puromycin (Sigma-Aldrich) based on previously pre-
formed killing curves. Transfected cells were further purified using FACS.
We confirmed knockdown efficiency by western blot.
Quantification of Nuclear Localization in Cells
Quantification of nuclear localization percentage was performed automati-
cally using BioTek Gen5 Data Analysis Software. First, we measured total
cell numbers by finding objects positive for the nuclear dye (Hoechst).
Next, we identified cells that exhibited higher GFP intensity in the nucleus
than in the cytosol, and thus calculated the percent of cells that exhibited nu-
clear localized TFEB (nuclear localization %). We reckon that this method
likely provides an underestimate of nuclear localization, because nuclear
GFP was harder to detect automatically in cells that express low levels of
TFEB-GFP. The N/C ratio was measured using CellProfiler version 2.1.1
(Broad Institute), as in (Carpenter et al., 2006; Han et al., 2011; Jones
et al., 2008).
Infection In Vitro
Bacteria were grown overnight at 37C in LB medium (Difco, BD) with
100 mg/ml streptomycin for Salmonella and Columbia medium (Difco, BD)
with 10 mg/ml Nalidixic acid for S. aureus. The following day, cultures were
diluted 1:50 in the same medium and grown at 37C for 3 hr to late-exponen-
tial phase, washed twice in cold PBS, and cells were infected at MOI 10 for
S. aureus and MOI 100 for S. enterica, as in (Trieu et al., 2009; Van Engelen-
burg and Palmer, 2010; Visvikis et al., 2014). For experiments using heat-
killed pathogen, bacteria were heated to 75C for 1 hr and 100% killing
was confirmed by culture for 48 hr on LB-streptomycin agar at 37C. For
gentamycin antibiotic (AB)-killed bacteria, before addition to RAW264.7 cells,
gentamicin (100 mg/ml) was added to washed bacteria in PBS for 2 hr, and
100% killing was confirmed by culture for 48 hr on LB-streptomycin agar
at 37C. The appropriate amount of bacteria was resuspended in DMEM
10% FBS without antibiotic, and cells were infected with indicated amounts
of bacteria.
Immunofluorescence
RAW264.7 TFEB-FLAG cells were seeded in 12-well plates containing NUNC
Thermanox coverslips. After treatment, cells were fixed with 4% paraformal-
dehyde (PFA) (pH 7.4) at room temperature for 10 min and washed three times
in PBS (Gibco Life Technologies,10010) for 5 min each. PFA was neutralized
with 50 mM NH4Cl in PBS at room temperature for 10 min with agitation. After
three washes with PBS, cells were permeabilized with 0.1% Triton X in PBS at
room temperature on agitator for 5min and then blockedwith 5%BSA (Sigma-
Aldrich, A9647) in PBS for 1 hr. After three washes with PBS, cells were incu-
bated with 1:400 monoclonal anti-FLAG antibody (Sigma-Aldrich, F1804) in a
humid chamber for 1 hr. Cells were washed three times in PBS and incubated
with the fluorescent secondary antibody plus Hoechst stain (Anaspec, AS-
83218) at room temperature in a humid chamber for 1 hr. After using prolong
anti-fade reagent (Life Technologies, P7481) as mounting media, coverslips
were stored at 4C until image acquisition using a Cytation 3 imaging plate
reader.Cell Reports 15, 1728–1742, May 24, 2016 1739
Immunoblotting
After time course of infection with S. enterica serovar Typhimurium SL1344,
RAW264.7 cells were washed three times with PBS, harvested, and lysed
with 13 SDS sample buffer Blue Loading Pack (Cell Signaling, 7722) at
100 ml per well of a six-well plate. Lysates were heated at 100C for 5 min
and then centrifuged for 5 min. The supernatant was collected and sonicated,
gel electrophoresis was performed using NuPAGE Novex 4%–12% Bis-Tris
protein gels (Life Technologies, NP0327), and then gels were transferred
onto nitrocellulose (Life Technologies, LC2009). After washing with TBS (Life
Technologies, 28358) for 5 min, membranes were soaked in blocking buffer
containing 13 TBS with 5% BSA for 1 hr at room temperature. After 3 washes
with TBS-Tween (Life Technologies, 28360), membraneswere incubated over-
night at 4C with primary antibodies and gentle agitation. Next membranes
were washed three times with TBS-Tween and incubated with HRP-conju-
gated secondary antibody (Cell Signaling, 7074 1:2,000) for 1 hr at room tem-
perature with gentle agitation. Membranes were then washedwith TBS-Tween
and incubated with LumiGLO (Cell Signaling Technology, 7003) for 1 min and
exposed to X-ray film (Denville Scientific, E3012). Quantification of western
blotting was performed by ImageJ software (NIH). The total level of protein
of interest was normalized to b-actin protein as control. Primary antibodies
and dilutions were as follows: b-actin antibody (1:1,000; Cell Signaling Tech-
nology, 4967), TFEB antibody (1:2,000; Bethyl Laboratories, A303-673A),
PKD1 + PKD2 + PKD3 antibody (1:1,000; Life Technologies, PA5-36113),
phospho-PKD (Ser916) antibody (1:1,000; Cell Signaling Technology, 2051),
phospho-PKCa/b II (Thr638/641) antibody (1:1,000; Cell Signaling Technol-
ogy, 9375), PKCa antibody (1:1,000; Cell Signaling Technology, 2056), phos-
pho-PKCz/l (Thr410/403) antibody (1:1,000; Cell Signaling Technology,
9378), Phospho-PKCd (Thr505) antibody (1:1,000; Cell Signaling Technology,
9374), and phospho-PKCd/q (Ser643/676) antibody (1:1,000; Cell Signaling
Technology 9376).
Drugs and Reagents
Drugs and reagents used included bisindolylmaleimide IV (5 mM; Cayman
Chemical, 13299); pan-PKC inhibitor, HBDDE (1 mM; Abcam, ab141573); se-
lective PKCa and PKCg inhibitor, kb-NB142-70 (10 mM; Abcam, ab141773);
selective PKD inhibitor, CRT0066101 (5 mM; Abcam, ab144637); selective
PKD inhibitor, LY333531 (10 mM; Cayman Chemical, 13964); selective inhibitor
of PKCb1 and PKCb2, PKCε inhibitor peptide (10 mM; Cayman Chemical,
13964); selective PKCε inhibitor, D609 (50 mM; Cayman Chemical, 13307);
phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitor, U-73122
hydrate (50 mM; Sigma-Aldrich, U6756); phosphoinositide-specific phospholi-
pase C (PI-PLC) inhibitor, CAY10594 (10 mM; Cayman Chemical, 13207); se-
lective phospholipase D2 (PLD2) inhibitor, VU0359595 (10 mM;Cayman Chem-
ical, 10955); selective phospholipase D1 (PLD1) inhibitor, halopemide (10 mM;
Cayman Chemical, 13205); and phospholipase D1 and phospholipase D2
inhibitor.
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